Cyclin E1 is essential for the re-entry of quiescent cells into the cell cycle. When hypomorphic mutant Myb mice (Myb
Introduction
Cell cycle progression relies on the timely modulation of Cyclins that bind and activate members of the Cyclin-Dependent Kinase (CDK) family, driving the cell from G 0 /G 1 to S-phase, through G 2 and lastly to initiate cell mitosis. Whilst the full length (FL) CyclinE1 isoform, termed El1, is detected in normal and malignant cells (1) , over-expression of up to five low molecular weight (LMW) CyclinE1 isoforms has been reported in malignant tissues (2) (3) (4) .
Amino-terminal truncated isoforms El2/3 and El5/6 arise by proteolytic cleavage of the full length protein by Elastase (5) or Calpain 2 (6) proteases. The isoform El4 is produced from an alternative translation start site (5) . LMW CyclinE1 truncations do not abolish the interaction of CyclinE1 with Cyclin/CDK inhibitors but may instead change the conformation of sites responsible for its inhibition thus subverting normal cell cycle control and stimulating cancer cells to progress through the cell cycle more efficiently (7, 8) . Importantly, the LMW isoforms of CyclinE1 are enzymatically hyperactive (5) .
De-regulation of CyclinE1 correlates with poor patient prognosis for those with breast cancer (9) , colorectal cancer (CRC) (3) and inflammatory bowel disease (10) . Additionally, overexpression of the LMW CyclinE1 isoform tracks with an increase in CDK2 activity in CRC (11) , a reduction in cell doubling time and an increase in S-phase progression (12, 13) . Furthermore, it is argued that proteolysis within the factors themselves or increased transactivation by E2F may result in dysregulated proliferation leading to genomic and chromosomal instability (CIN).
We investigated whether CyclinE1 (Ccne1) is regulated by the proto-oncogene and transcription factor Myb. We previously showed that cell cycle re-entry, progression and proliferation appear retarded within the colonic crypts of Myb
Plt4/Plt4
hypomorphic mutant mice, which correlated with a significant reduction in Ccne1 expression (14, 15) . These data suggested that the cell cycle defects observed in the Myb hypomorphs may be due in-part to reduced Ccne1 expression. Others have found in prostate carcinoma that Cyclin (A1, D1 and E1) expression is induced upon Myb over-expression and decreases upon Myb silencing (16) . Furthermore, in Jurkat T-cells Myb has been shown to regulate the Ccne1 promoter (17) . A functional link between Myb and members of the cell cycle regulatory apparatus has also been described (18, 19) .
Myb over-expression is a feature of CRC (20) and here we demonstrate that Myb is a transactivator of Ccne1. We observe co-expression of Myb and CyclinE1 protein within 
Materials and Methods

Mice
Myb
Plt4/Plt4
hypomorphic mutant mice were generated at the Walter and Eliza Hall Institute and their hematopoietic and colon defects described (15, 21 
Blood cell count
Blood was collected from mice prior to culling by retro-orbital or tail-vein blood collection and blood cell counts determined using CELL-DYN Sapphire Hematology Analyzer.
Cell lines, tumor cell injections and shRNA
The propagation and derivation of CT26, MC38, YAMC and NIH3T3 cell lines have been described in detail elsewhere (14) . Lentiviral small hairpin RNA particles (cyclinE1; NM007633/TRCN0000077777) were purchased from Sigma. Single cell clones were selected in the presence of puromycin, expanded and stable KD (and control vector PLKO.1-PURO) clones reconfirmed by qRT-PCR and western blotting. CT26 tumor cells (0.5 x 10 6 ) were subcutaneously injected into syngeneic BALB/c mice in the right lower flank. Tumors were measured using an electronic caliper. CRC cell line authenticity was evaluated by RNAseq profiling and their capacity to form tumors in syngeneic mice.
Chromosome Spreads
CT26 cells were seeded overnight at 10 5 cells. Colchicine (10 µg/ml, Sigma) was added to the media for 1hr and the cells harvested. After KCl (75mM) treatment and fixation with methanol:glacial acetic acid (3:1), cells were dropped onto polylysine slides and allowed to dry 6 before quick diff staining and mounting. Chromosome numbers were scored using a BX51 Zeiss microscope.
Western blotting
Whole cell lysates were generated by incubating primary intestinal crypt cells and cell lines in 0.5% TX-100 lysis buffer followed by nuclei shearing using a 29 gauge needle. Proteins were separated on 4-12% Bis-Tris pre-cast gels (NuPAGE) and transferred to a PVDF membrane.
Membranes were blocked in 10% non-fat skim milk powder and probed with antibodies (Supplementary Table 1 ). Membranes were probed with HRP secondary antibodies (Bio-Rad) and proteins detected using ECL.
Histology
Crypts and adenomas were fixed in 10% normal buffered formalin, embedded in paraffin and 2μm consecutive sections generated to capture same cell sectioning. Sections were stained with hematoxylin and eosin (H&E). CT26 subcutaneous tumors were halved and fixed in PFA4% overnight and the remaining piece frozen down at -80°C for subsequent RNA extraction. All human primary CRC specimens and matched normal tissues were collected at the Royal Melbourne Hospital, Australia. All patients gave informed consent for their de-identified samples and clinical data to be used in human ethics approved research. Tissue specimens were embedded in optimal cutting temperature compound and H&E-stained. Tumors were macrodissected to greater than 70% neoplastic cell content before total RNA was extracted.
Immunohistochemistry
Immunohistochemistry (IHC) was performed using Envision kit (Dako). Antigen retrieval was performed in 10 mM Tris-buffer and 1 mM EDTA (pH 8) in a pressure cooker (Biocare Decloker) at 125ºC for 3 min. Slides were allowed to cool and washed with dH 2 0, followed by 
Chromatin immunoprecipitation assays and transfection of NIH3T3 cells
Protocols have been described in detail previously (14) . Primers used in the ChIP analyses are described (Supplementary Table 2 ).
Chloramphenicol reporter assays and qRT-PCR analyses
pCyclinE3.2CAT-Basic-MCSII (3.2 kb of the Ccne1 promoter) and pCyclinE4.8CAT-Basic-MCSII (4.82 kb of the Ccne1 promoter) were generated by Gateway cloning Ccne1 promoter PCR fragments into pCAT-Basic-MCSII. Primers used for cloning are described (Supplementary Table   2 ). pCMV E2F-1 was a gift of Dr Patrick. Humbert (PMCC). Protocols for CAT reporter assays and q-RT-PCR analysis have been described previously (14) . Primers used for qRT-PCR are described (Supplementary Table 2 ).
Murine intestinal and adenoma organoid cultures
Colon organoids were generated using previously established protocols (22) .
Electrophoretic mobility shift assay (EMSA)
EMSAs were performed with a [ 32 P]-labeled mimA DNA probe and 1µl of HIS-tagged Myb CTL protein (23) in reactions containing 10mM Tris pH 8.0, 50mM NaCl, 2.5% glycerol, 1mM EDTA, 0.25mg/ml BSA and 1μg/ml poly (dI-dC) as previously described (24) . Binding reactions were resolved on 0.5 x TBE 6% non-denaturing PAGE (29:1) gels (24) . Gels were dried and quantified by PhosphorImager analysis using Image Quant Software. 
Quantitation and Statistics
Results
Myb and CyclinE1 are co-expressed in intestinal cells and adenomas
To explore the relationship between Myb and CyclinE1 (Ccne1), qRT-PCR analysis was performed on mouse CRC cell lines. Myb expression was high in the MC38 cells compared to the immortalised colon epithelial cell line YAMC, and this corresponded with the high levels of Ccne1 mRNA (Fig. 1A and B) . CyclinE1 protein can be expressed as different isoforms (2-4) (Fig. 1C) however, the predominantly expressed isoform of CyclinE1 in MC38 and YAMC extracts was the ~25-30kDa LMW isoform (Fig. 1D ).
Western blot analysis was also performed on small intestinal (SI) crypt lysates derived from
WT and Myb
Plt4/Plt4
hypomorphic mutant mice that we had previously reported to express reduced Ccne1 mRNA levels and display colonic crypt defects (15) . The efficacy of the antibody in detecting both the FL and LMW forms of CyclinE1 was confirmed in NIH3T3 cells (Fig. 1D) . IHC was employed to confirm the presence of MYB and CyclinE1 in normal human colon at the protein level. We observed that MYB expression was predominantly nuclear as expected, while CyclinE1 expression was mostly cytoplasmic as well as nuclear (Fig. 1E ). This subcellular localization was recapitulated in human adenomas ( Fig. 1F ) and is consistent with subcellular expression patterns reported for other tumor cells (25) . This analysis was then extended to a larger set of primary human samples where we focused on cancer precursors, colonic adenomas and found that MYB and CCNE1 mRNA levels were elevated compared to matched-normal crypts ( Fig. 1G and H) .
Myb activates the Ccne1 promoter
The above observations suggested that Myb might regulate Ccne1 expression. To test whether Ccne1 was a direct transcriptional target of Myb, an in silico analysis was performed on the mouse (Supplementary Fig. 1 ) and human ( Supplementary Fig. 2 ) Ccne1/CCNE1 promoters to identify potential Myb binding elements (MBEs) (26) . Multiple MBEs were observed throughout the Ccne1/CCNE1 promoters and these clustered within a 2 kb proximal and a 4 kb distal region upstream of the transcription start sites ( Fig. 2A ).
To confirm Myb occupancy on the CyclinE1 promoter we performed ChIP assays on colonic crypts using a chicken IgY antibody raised against the mouse GST-Myb fusion protein with the DNA binding domain deleted. As a control we employed a IgY antibody directed against GST.
Both were affinity purified on antigen columns and have been characterized previously (14) .
Binding of Myb correlated with active chromatin (AcH3K27 mark) in WT crypts ( (14) and we noted several potential high affinity β-catenin/TCF-4 binding motifs within the murine Ccne1 promoter ( Fig. 2A and Supplementary Fig. 1 ). However, we did not observe significant β-catenin occupancy on the Ccne1 promoter ( Fig. 2B and C).
We next examined whether Myb had a direct functional effect on the mouse Ccne1 promoter activity. CAT reporters containing a 3.2kbp or 4.8kbp region of the Ccne1 promoter regulation has been ascribed to the transcription factor E2F1 (27) . We confirmed this relationship with both the pCyclinE3.2CAT and pCyclinE4.8CAT reporters showing that exogenous E2F1 can robustly activate these promoters ( Fig. 2D and E As Myb positively auto-regulates its own promoter (14, 31) , reporter assays can be performed on the Myb promoter. These revealed an inability of full-length Myb WT to achieve maximal auto-regulation of its own promoter in the presence of Myb Plt4 (Fig. 3E) . A similar inhibitory effect was also observed by Myb Plt4 on the 4.8kb Ccne1 promoter (Fig. 3F) .
Defective Myb function perturbs colon organoid formation and reduces CyclinE1 expression in colon adenomas
Previously, we have shown that reduced Ccne1 expression in Myb Plt4/Plt4 SI organoids correlated with defects in cell cycle re-entry, progression, and proliferation (14) . We also described defects in cell cycle progression in the colonic crypts of Myb Plt4/Plt4 hypomorphic mice (15) . To further our understanding of this relationship between Myb and CyclinE1 specifically in the colon because this is the most clinically relevant to CRC in patients, we sought to assess the impact of Myb on Ccne1 expression and colonic organoid cultures (22) . Myb ) reduced CyclinE1 IHC staining was observed (Fig. 4D ). This was also confirmed at the mRNA level (Fig. 4E ). Collectively the above data underscore the regulatory relationship between Myb and Ccne1 in the colon as well as in this pre-malignant stage of CRC development.
CyclinE1 KD effects on CRC cell proliferation and tumor growth
The above data prompted us to examine the Myb-CyclinE1 axis further with the view that
Ccne1 may also play a role in regulating proliferation in established CRC tumor cells. To this end we sought to assess the effects of CyclinE1 knockdown (KD) in CT26 CRC cells. CT26
expresses robust levels of CyclinE1 and following transduction of shRNAs (KD4) directed against Ccne1 mRNA we were successful in reducing protein expression in bulk culture (data not shown) and in two single cell clones (Fig. 5A) . KD confirmation was determined in replicate western blotting experiments (Fig. 5B ). When these cells were propagated under growth limiting conditions (0.2 % FCS) modest effects on cell growth using the MTT assay at day 4 were observed ( Fig. 5C ). The two CT26 CyclinE1 KD clones were then assessed for their capacity to form tumors when injected subcutaneously into BALB/c mice (33) . CyclinE1 KD significantly reduced tumor formation particularly in the case of clone #1 (Fig. 5D) . Furthermore, in clone#1, but not clone#10, spleen weights in tumor bearing mice were also reduced ( Fig. 5E and F) . This is consistent with the systemic effects of high CT26 tumor burden on splenomegaly in mice.
CyclinE1 KD effects on chromosome stability
One of the pleiotropic consequences of CyclinE1 over-expression in cancer cells is the promotion of chromosomal instability. Therefore we performed karyotype analysis of CT26 cells and found that parental CT26 cells showed highly variable ploidy (Fig. 6A) . By contrast, we found that cells with CyclinE1 KD had significantly stabilized cell karyotypes (Fig. 6A-C) . This Red blood cell parameters in adult the WT C57BL/6 mice were consistent with other reports (37, 38) . However, the defect of thrombocytosis was the most overt blood profile difference 
Discussion
We have previously observed that hypomorphic Myb mutant mouse intestinal and colon crypts showed reduced Ccne1 expression (14, 15) . These data prompted us to investigate whether Myb directly regulated Ccne1 and to explore the concept that elevated Myb in CRC (40) may be responsible for promoting Ccne1/CyclinE1 expression that drives cell proliferation and tumor growth. When Myb was elevated in mouse and human CRC cells and adenomas Cnne1 expression was increased. We also observed that in the highly proliferative cells of the intestinal crypts from the SI and colon, that the LMW CyclinE1 isoform was the predominant form expressed. These data suggest that LMW CyclinE1 expression is not restricted to transformed cells.
Promoter analysis showed that the Ccne1 promoter contained several MBEs, suggesting that 
We have also shown the DNA binding activity of Myb 
(42), chromosomal instability (43) and defects in the assembly of the mini chromosome maintenance complex resulting in premature mitosis entry (44, 45) .
Previously, we reported a parallel increase in aneuploidy in primary and metastatic CRC with elevated Myb expression (46) . Indeed activated CyclinE1 through its promotion of CIN accelerates LOH (47) 
